Central Garden & Pet (NASDAQ:CENTA) Upgraded by BidaskClub to Buy

Share on StockTwits

BidaskClub upgraded shares of Central Garden & Pet (NASDAQ:CENTA) from a hold rating to a buy rating in a report issued on Thursday, BidAskClub reports.

Other research analysts also recently issued research reports about the company. KeyCorp lowered their target price on Central Garden & Pet from $39.00 to $36.00 and set an overweight rating for the company in a research note on Friday, August 2nd. Monness Crespi & Hardt reissued a buy rating and set a $36.00 target price (down previously from $44.00) on shares of Central Garden & Pet in a research note on Friday, August 2nd. Finally, Zacks Investment Research raised Central Garden & Pet from a sell rating to a hold rating in a research note on Tuesday, August 20th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have assigned a buy rating to the stock. Central Garden & Pet presently has an average rating of Buy and a consensus price target of $38.50.

Shares of NASDAQ CENTA opened at $26.88 on Thursday. The company has a current ratio of 4.84, a quick ratio of 3.17 and a debt-to-equity ratio of 0.67. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 14.07, a PEG ratio of 2.77 and a beta of 0.12. Central Garden & Pet has a 12 month low of $20.50 and a 12 month high of $36.96. The stock has a 50-day moving average price of $23.67 and a two-hundred day moving average price of $25.01.

Central Garden & Pet (NASDAQ:CENTA) last issued its earnings results on Thursday, August 1st. The company reported $0.80 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.86 by ($0.06). The business had revenue of $706.58 million for the quarter, compared to analyst estimates of $689.17 million. Central Garden & Pet had a return on equity of 9.66% and a net margin of 4.30%. On average, sell-side analysts predict that Central Garden & Pet will post 1.73 earnings per share for the current year.

Large investors have recently added to or reduced their stakes in the company. Quantamental Technologies LLC bought a new stake in shares of Central Garden & Pet during the second quarter worth about $50,000. Amundi Pioneer Asset Management Inc. bought a new stake in shares of Central Garden & Pet during the first quarter worth about $56,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Central Garden & Pet by 30.4% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,454 shares of the company’s stock valued at $80,000 after acquiring an additional 805 shares during the last quarter. Advisory Services Network LLC bought a new stake in Central Garden & Pet in the second quarter valued at approximately $94,000. Finally, NumerixS Investment Technologies Inc bought a new stake in Central Garden & Pet in the first quarter valued at approximately $142,000. Institutional investors own 67.12% of the company’s stock.

About Central Garden & Pet

Central Garden & Pet Company, together with its subsidiaries, produces and distributes products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments, Pet and Garden. The Pet segment supplies products for dogs and cats, including edible bones, edible and non-edible chews, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and products for birds, small animals, and specialty pets, such as food, cages and habitats, toys, chews, and related accessories.

See Also: What is a Tariff?

Receive News & Ratings for Central Garden & Pet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Central Garden & Pet and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Investment Analysts’ Price Target Changes for October, 14th
Investment Analysts’ Price Target Changes for October, 14th
Civic  Market Cap Achieves $26.92 Million
Civic Market Cap Achieves $26.92 Million
TRAXIA Tops 24-Hour Trading Volume of $207.00
TRAXIA Tops 24-Hour Trading Volume of $207.00
TOP  Price Hits $0.0022
TOP Price Hits $0.0022
Syndax Pharmaceuticals  Stock Rating Upgraded by Zacks Investment Research
Syndax Pharmaceuticals Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America  Stock Rating Upgraded by Zacks Investment Research
Laboratory Corp. of America Stock Rating Upgraded by Zacks Investment Research


 
© 2006-2019 Zolmax.